Alex Sapir
About Alex Sapir
Alex Sapir serves as the Chief Executive Officer of Fulcrum Therapeutics, bringing extensive experience from various leadership roles in the pharmaceutical industry. He has a strong background in marketing and sales, having previously held positions at companies such as United Therapeutics and Dova Pharmaceuticals.
Work at Fulcrum
Alex Sapir serves as the Chief Executive Officer at Fulcrum Therapeutics, a position he has held since 2023. His role involves overseeing the strategic direction and operational management of the company, which is based in Boston, Massachusetts. Under his leadership, Fulcrum focuses on advancing its pipeline of innovative therapies aimed at treating genetic diseases.
Education and Expertise
Alex Sapir holds a Bachelor of Arts in Economics from Franklin & Marshall College, which he completed from 1984 to 1988. He furthered his education by obtaining a Master of Business Administration with a focus on Finance and Strategy from Harvard Business School between 1995 and 1997. His academic background supports his extensive experience in marketing, sales, and corporate strategy within the pharmaceutical industry.
Background
Alex Sapir has a diverse professional background in the pharmaceutical and biotechnology sectors. He began his career at GlaxoSmithKline, where he held various roles, including Management Trainee and Director of Sales and Marketing in Hungary. He later served as Senior Director of Marketing at Guilford Pharmaceuticals and as Executive Vice President of Marketing and Sales at United Therapeutics, where he significantly expanded the company's product offerings.
Achievements
During his tenure as President and CEO at Dova Pharmaceuticals, Alex Sapir led the company through a successful Initial Public Offering, raising $160 million. He transformed Dova into a fully-integrated biotech company with a robust product pipeline. Additionally, he authored a Harvard Business School case study titled 'Bausch and Lomb: Pressure to Perform,' which is utilized in business education across the country.
Previous Positions
Before his current role at Fulcrum, Alex Sapir held several key positions in the pharmaceutical industry. He worked as an Independent Board Member at PhaseBio Pharmaceuticals from 2020 to 2023. He also served as a Faculty Lecturer at The Wharton School for five months in 2023, teaching marketing principles. His earlier roles include positions at GSK and ZS Associates, where he contributed to corporate strategy and marketing initiatives.